Ovarian Cancer Screening and AI

Study acronym: AI-OCS-Gyn
StatusCompleted
PhaseNot applicable
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Completed without a posted recruiting period Show 6 more changesShow less
    • Final enrollment: 300 participants (planned 350)
    • Primary completion date changed from estimate of Apr 30, 2026 to Sep 15, 2026
    • Secondary endpoints: details revised at 1 of 2 entries
    • Publications: details revised at 3 of 3 entries
    • Eligibility criteria expanded, about 3 words
    • Study description expanded, about 2 words
  2. Study First Submitted
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Gynecologists frequently overestimate the benefits and safety of ovarian cancer screening. AI-supported discussions may help correct these misperceptions. This study tests whether an AI-guided conversation about the evidence on ovarian cancer screening can improve gynecologists' knowledge and reduce non-evidence-based screening recommendations, compared with a control AI discussion on ovarian cancer prevalence.
Trial Details
NCT Number NCT07503054
Lead Sponsor Charite University, Berlin, Germany
Collaborators: Max Planck Institute for Human Development, German Research Foundation
Conditions
(from sponsor)		 Ovarian Cancer Screening Recommendations by Gynecologists
Enrollment 300 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov